Elixir Pharmaceuticals Obtains $12,000,000 New Financing

  • Feed Type
  • Date
    5/19/2009
  • Company Name
    Elixir Pharmaceuticals
  • Mailing Address
    12 Emily Street Cambridge, MA 02139
  • Company Description
    Elixir Pharmaceuticals is a genomics-based drug discovery company developing a new category of pharmaceuticals that treat and/or prevent the broad spectrum of diseases that accompany aging.
  • Website
    http://www.elixirpharm.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $12,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MPM Capital
  • Venture Investor
    Novartis
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Oxford Bioscience Partners
  • Venture Investor
    Physic Ventures
  • Venture Investor
    Undisclosed